Literature DB >> 24417398

Contrast-enhanced cardiovascular magnetic resonance imaging of coronary vessel wall: state of art.

Yen-Shu Kuo1, Sebastian Kelle, Charlotte Lee, Rocio Hinojar, Eike Nagel, Rene Botnar, Valentina O Puntmann.   

Abstract

Coronary wall imaging by cardiovascular magnetic resonance (CMR) emerges as a promising method to detect vascular injury and remodeling directly within the coronary vascular wall. In this review, the current evidence on coronary wall enhancement using CMR is presented and summarized, with particular focus on its ability to detect inflammation in atherosclerosis, Takayasu's arteritis, acute coronary syndromes and immune-mediated inflammatory vasculitides. The authors review the possible mechanisms of coronary wall contrast enhancement on CMR and discuss the technical considerations and limitations. Lastly, the potential clinical applications and possibilities for future research are proposed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24417398     DOI: 10.1586/14779072.2014.877838

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Coronary plaque burden regression and high-risk plaque reversal: Potential biomarkers for secondary prevention?

Authors:  Janet Wei; Daniel S Berman; Debiao Li
Journal:  Trends Cardiovasc Med       Date:  2015-08-18       Impact factor: 6.677

2.  Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients.

Authors:  Niharika Varma; Rocio Hinojar; David D'Cruz; Eduardo Arroyo Ucar; Andreas Indermuehle; Sarah Peel; Gerald Greil; Nicholas Gaddum; Phil Chowienczyk; Eike Nagel; Rene M Botnar; Valentina O Puntmann
Journal:  JACC Cardiovasc Imaging       Date:  2014-07-16

3.  Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.

Authors:  Constantin von Zur Mühlen; Simon Reiss; Axel J Krafft; Lisa Besch; Marius Menza; Manfred Zehender; Timo Heidt; Alexander Maier; Thomas Pfannebecker; Andreas Zirlik; Jochen Reinöhl; Peter Stachon; Ingo Hilgendorf; Dennis Wolf; Philipp Diehl; Tobias Wengenmayer; Ingo Ahrens; Christoph Bode; Michael Bock
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.